Pure Global

Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia - Trial NCT06021795

Access comprehensive clinical trial information for NCT06021795 through Pure Global AI's free database. This phase not specified trial is sponsored by Third Wave Therapeutics and is currently Recruiting. The study focuses on Insomnia. Target enrollment is 25 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06021795
Recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov • NCT06021795
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia

Study Focus

Insomnia

Sound Treatment

Interventional

device

Sponsor & Location

Third Wave Therapeutics

San Francisco, United States of America

Timeline & Enrollment

N/A

Aug 01, 2023

Mar 31, 2024

25 participants

Primary Outcome

Change in Insomnia Severity Index (ISI)

Summary

Assess the effect of a customized audio track delivered via standard commercially-available
 bone conduction headsets on the quality of sleep

ICD-10 Classifications

Nonorganic insomnia
Disorders of initiating and maintaining sleep [insomnias]
Sleep disorders
Sleep disorder, unspecified
Other sleep disorders

Data Source

ClinicalTrials.gov

NCT06021795

Device Trial